| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
36,153 |
29,961 |
$2.81M |
| 99215 |
Prolong outpt/office vis |
21,641 |
14,284 |
$2.30M |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
6,118 |
5,586 |
$911K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,354 |
9,107 |
$580K |
| J2315 |
Injection, naltrexone, depot form, 1 mg |
429 |
390 |
$540K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,579 |
3,340 |
$438K |
| 96127 |
|
33,718 |
29,192 |
$369K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
9,867 |
8,936 |
$343K |
| 80305 |
|
16,641 |
14,650 |
$186K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,187 |
1,966 |
$180K |
| Q9992 |
Injection, buprenorphine extended-release (sublocade), greater than 100 mg |
85 |
76 |
$141K |
| 99205 |
Prolong outpt/office vis |
982 |
915 |
$137K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,276 |
1,229 |
$120K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
975 |
927 |
$89K |
| 99385 |
|
519 |
494 |
$56K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,400 |
2,542 |
$39K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,756 |
1,676 |
$31K |
| 99401 |
|
1,087 |
744 |
$29K |
| H0001 |
Alcohol and/or drug assessment |
267 |
240 |
$25K |
| 99417 |
Prolong home eval add 15m |
340 |
294 |
$20K |
| 36415 |
Collection of venous blood by venipuncture |
9,302 |
8,219 |
$19K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
323 |
155 |
$15K |
| 90715 |
|
295 |
281 |
$13K |
| 90686 |
|
728 |
691 |
$11K |
| 99402 |
|
228 |
215 |
$11K |
| 93000 |
|
633 |
591 |
$10K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
1,068 |
909 |
$10K |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
943 |
837 |
$10K |
| 97803 |
|
140 |
101 |
$9K |
| 99000 |
|
4,957 |
4,261 |
$8K |
| 87631 |
|
71 |
68 |
$8K |
| 99386 |
|
62 |
58 |
$7K |
| 20553 |
|
214 |
186 |
$7K |
| 90674 |
|
364 |
354 |
$7K |
| 87428 |
|
98 |
96 |
$7K |
| 97802 |
|
130 |
74 |
$6K |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
196 |
180 |
$5K |
| 81002 |
|
3,215 |
2,984 |
$4K |
| 81025 |
|
521 |
467 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
464 |
431 |
$4K |
| G3002 |
Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan that includes strengths, goals, clinical needs, and desired outcomes; overall treatment management; facilitation and coordination of any necessary behavioral health treatment; medication management; pain and health literacy counseling; any necessary chronic pain related crisis care; and ongoing communication and care coordination between relevant practitioners furnishing care, e.g. physical therapy and occupational therapy, complementary and integrative approaches, and community-based care, as appropriate. required initial face-to-face visit at least 30 minutes provided by a physician or other qualified health professional; first 30 minutes personally provided by physician or other qualified health care professional, per calendar month. (when using g3002, 30 minutes must be met or exceeded.) |
393 |
362 |
$3K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
225 |
214 |
$2K |
| 99173 |
|
257 |
249 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
132 |
127 |
$2K |
| 0013A |
|
48 |
47 |
$2K |
| 62323 |
|
28 |
26 |
$2K |
| 0003A |
|
42 |
41 |
$1K |
| 0134A |
|
36 |
31 |
$1K |
| 27096 |
|
14 |
13 |
$1K |
| 99408 |
|
66 |
38 |
$1K |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
41 |
38 |
$1K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
26 |
13 |
$1K |
| 90682 |
|
29 |
29 |
$1K |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
159 |
143 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
17 |
14 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
51 |
43 |
$946.41 |
| 90837 |
Psychotherapy, 53 minutes with patient |
123 |
74 |
$826.65 |
| 81007 |
|
44 |
41 |
$781.31 |
| 71046 |
Radiologic examination, chest; 2 views |
25 |
24 |
$744.18 |
| 99490 |
Ccm add 20min |
43 |
41 |
$570.54 |
| 0124A |
|
15 |
14 |
$550.00 |
| 80061 |
Lipid panel |
39 |
39 |
$546.03 |
| 0011A |
|
13 |
13 |
$520.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
19 |
12 |
$511.22 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
187 |
169 |
$510.00 |
| 20610 |
|
15 |
12 |
$448.89 |
| 90662 |
|
15 |
15 |
$232.60 |
| 82947 |
|
40 |
40 |
$167.27 |
| 90834 |
Psychotherapy, 45 minutes with patient |
141 |
79 |
$141.08 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
33 |
28 |
$136.24 |
| 99397 |
|
12 |
12 |
$82.64 |
| 96160 |
|
153 |
138 |
$80.99 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
62 |
54 |
$74.39 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
76 |
71 |
$60.29 |
| G0136 |
Administration of a standardized, evidence-based assessment of physical activity and nutrition, 5-15 minutes, not more often than every 6 months |
14 |
13 |
$37.30 |
| G0008 |
Administration of influenza virus vaccine |
38 |
36 |
$22.24 |
| 91300 |
|
109 |
103 |
$16.00 |
| 1111F |
|
1,169 |
1,018 |
$7.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
43 |
42 |
$1.36 |
| 3074F |
|
22,593 |
19,706 |
$0.00 |
| 3080F |
|
2,820 |
2,577 |
$0.00 |
| 1036F |
|
12,950 |
10,690 |
$0.00 |
| 3075F |
|
4,776 |
4,425 |
$0.00 |
| 3008F |
|
26,794 |
23,015 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
52 |
50 |
$0.00 |
| 3079F |
|
13,088 |
11,712 |
$0.00 |
| 1034F |
|
3,662 |
3,038 |
$0.00 |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
47 |
45 |
$0.00 |
| 1123F |
|
150 |
135 |
$0.00 |
| 1126F |
|
317 |
280 |
$0.00 |
| 1035F |
|
667 |
577 |
$0.00 |
| 1125F |
|
456 |
417 |
$0.00 |
| 3044F |
|
90 |
84 |
$0.00 |
| 91301 |
|
88 |
86 |
$0.00 |
| J3490 |
Unclassified drugs |
18 |
17 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
41 |
40 |
$0.00 |
| 3725F |
|
11,793 |
10,631 |
$0.00 |
| 1159F |
|
20,954 |
17,781 |
$0.00 |
| 3078F |
|
14,045 |
12,487 |
$0.00 |
| 3077F |
|
2,754 |
2,505 |
$0.00 |
| 1160F |
|
592 |
488 |
$0.00 |
| 3288F |
|
138 |
121 |
$0.00 |
| 91313 |
|
36 |
31 |
$0.00 |
| 3046F |
|
14 |
12 |
$0.00 |
| G0446 |
Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes |
53 |
46 |
$0.00 |
| 91312 |
|
15 |
14 |
$0.00 |